FDA clears a new type of cholesterol-lowering drug, Esperion Therapeutics’ Nexletol
Americans struggling to lower their cholesterol will have another drug at their disposal, after the U.S. Food and Drug Administration approved a new medicine from Esperion Therapeutics Inc.
Esperion’s once-daily pill, bempedoic acid, is the first oral non-statin approved in nearly two decades. The drug works differently than others to lower bad cholesterol, LDLs, and ultimately forces it out of a patient’s bloodstream. Doctors see the drug as an alternative for millions of patients who can’t take or aren’t responding to statins—a...
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Healthy 'Mediterranean Diet' Is Good for Your MicrobiomeThe Mediterranean diet is already considered one of the healthiest for your heart, and now scientists say it may give your gut bacteria a boost, too.
Les mer »
Exclusive: Canadian regulator considers changes to new drug pricing planCanada's drug pricing agency is contemplating significant changes to how it...
Les mer »
Here’s a New Type of Headband to TryWe might as well surrender now to Prada’s newest headband — mainly because they’re very pretty, but also because they look menacingly sharp
Les mer »
The Weeknd Says He Has an ''Off-and-On'' Relationship With DrugstestaThe Weeknd opens up again about his drug use, past and present, in a revealing new interview with CR Men.
Les mer »